++++++++++++++++++++
+
+++
+TECHNOLOGy ��� +++
++++++++++++++++++++
Novel Technologies to
Treat Cancer of the Liver at
Akron General Medical center
Kevin M. Lowe, MD, is a hepatobiliary/pancreatic surgeon, reportedly the only one between Cleveland and Columbus. In
November, Dr. Lowe began utilizing a new image-guided system for liver surgery at Akron General Medical Center.
PHOTO �� SMITHBERGER PHOTOGRAPHY, NORTH CANTON
P
is
relatively uncommon in the
United States, although its
incidence is rising, principally
in relation to the spread of Hepatitis C
infection. According to the National
Cancer Institute, metastatic cancer of
the liver is far more common. In fact,
the liver (along with the lung and bones)
is one of the three most common sites of
cancer metastasis.
At Akron General Medical Center,
two physicians ��� Kevin M. Lowe, MD,
and David M. Isaacs, DO ��� recently
introduced novel technologies to treat
both primary and metastatic cancer of
the liver.
Dr. Lowe is a hepatobiliary/pancreatic
surgeon who completed his fellowship
training at Methodist Dallas Medical
Center. He is certified by the Americas
Hepato-Pancreato-Biliary Association
(AHPBA) and is reportedly the only
certified specialist of his kind between
Cleveland and Columbus. In November,
Dr. Lowe began utilizing a new imageguided system for liver surgery.
Dr. Isaacs is a board-certified diagnostic radiologist who completed fellowship
training in interventional radiology at
Cleveland Clinic. A member of Radiology
& Imaging Services, Inc., Dr. Isaacs
recently introduced small particle technology called SIR-Spheres to patients
with cancer of the liver at Akron General
Medical Center.
RIMARY LIVER CANCER
